Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06672497 · ClinicalTrials.gov registry record

Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients

A clinical trial of Breast Cancer and Gynecologic Cancers, sponsored by University of South Carolina.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT06672497 is a study of Breast Cancer and Gynecologic Cancers that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06672497, a study of Breast Cancer and Gynecologic Cancers, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Participants recruited for this study will be breast cancer or gynecological cancer patients who agree to participate in an exercise study examining the effects of chemotherapy on muscle mitochondrial oxidative capacity, a measure of skeletal muscle health. Participants will ride a stationary bicycle and the quadriceps muscle will be non-invasively evaluated.

Study Locations (1)

South Carolina

  • Prisma Health Cancer Institute - Greenville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-09-07
Est. Completion 2026-03

Sponsor

University of South Carolina

157 total trials

What the Registry Record Tells You About NCT06672497

The ClinicalTrials.gov registry entry for NCT06672497 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT06672497 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06672497 about?

NCT06672497 is a clinical study titled "Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients". Participants recruited for this study will be breast cancer or gynecological cancer patients who agree to participate in an exercise study examining the effects of chemotherapy on muscle mitochondrial oxidative capacity, a measure of skeletal muscle health. Participants will ride a stationary bicycl...

What is the current status of trial NCT06672497?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2021-09-07. Estimated completion is 2026-03.

What conditions does trial NCT06672497 study?

This clinical trial studies the following conditions: Breast Cancer, Gynecologic Cancers, Mitochondrial Function.

Who is sponsoring clinical trial NCT06672497?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06672497 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.